Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Candidates are determined through medical evaluation
How IGF-1 LR3 Works Reduced IGFBP binding The N-terminal extension and R3 substitution disrupt binding to IGF-binding proteins, keeping LR3 free in plasma rather than sequestered
People with a history of pituitary disorders, uncontrolled diabetes, or active retinopathy should also avoid growth hormone therapies without careful medical evaluation
Research Use Notice KLOW Blend is provided strictly for laboratory research and development purposes
doi:10.1172/jci116842 Pickart L, Vasquez-Soltero JM, Margolina A
Some labs do run both blends in parallel research designs to compare outcomes with and without KPV, though study design should follow each lab's own protocol requirements
US$ 29.03
US$ 22.68
US$ 20.40
US$ 29.17
US$ 29.31
US$ 27.31
